Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

Article metrics

  • 201 Accesses

Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-42237-3, published online 16 April 2019

The Acknowledgements section of this Article is incomplete.

“Funded by NIH R21 CA184612-01 and Melanoma Research Foundation CDA Grant Award (A.V.). NIH R01 CA204806 (N.L.). We would like to acknowledge the important technical contributions and advice of Kimberlyn Acklin, MS, SCYM(ASCP), at The George Washington University Flow Cytometry Core Facility and Bethany Rentz, RVT, at The George Washington University Office of Animal Research.”

should read:

“Funded by NIH R21 CA184612-01 and Melanoma Research Foundation CDA Grant Award (A.V.), NIH R01 CA204806 (N.L.), Czech Science Foundation (No 15-19640S), the CAS (RVO: 86652036) and the project „BIOCEV” (CZ.1.05/1.1.00/02.0109) from the ERDF (C.B.). We would like to acknowledge the important technical contributions and the advice of Kimberlyn Acklin, MS, SCYM(ASCP), at The George Washington University Flow Cytometry Core Facility and Bethany Rentz, RVT, at The George Washington University Office of Animal Research.”

Author information

Correspondence to Alejandro Villagra.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Knox, T., Sahakian, E., Banik, D. et al. Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep 9, 14824 (2019) doi:10.1038/s41598-019-51403-6

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.